A monocyte-centered framework for predicting immunochemotherapy efficacy in lung squamous cell carcinoma patients - PubMed
7 hours ago
- #biomarker
- #immunochemotherapy
- #monocyte
- Monocytes may predict immunochemotherapy efficacy in lung squamous cell carcinoma.
- Responders showed higher baseline levels of peripheral blood and tumor-infiltrating monocytes.
- APOBEC3A+ monocytes were associated with better treatment response.
- Findings validated using routine blood tests and tissue analysis.
- Study suggests monocyte parameters link systemic immunity and tumor microenvironment.